Form 8-K - Current report:
SEC Accession No. 0001601485-26-000048
Filing Date
2026-06-17
Accepted
2026-06-17 08:03:10
Documents
18
Period of Report
2026-06-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K angn-20260617.htm   iXBRL 8-K 23900
2 EX-99.1 a2026-06x17xxeltxxxmulti.htm EX-99.1 18395
6 a2026-06x17xxeltxxxmulti001.jpg GRAPHIC 259997
7 a2026-06x17xxeltxxxmulti002.jpg GRAPHIC 249380
8 a2026-06x17xxeltxxxmulti003.jpg GRAPHIC 243581
9 a2026-06x17xxeltxxxmulti004.jpg GRAPHIC 280085
10 a2026-06x17xxeltxxxmulti005.jpg GRAPHIC 247812
11 a2026-06x17xxeltxxxmulti006.jpg GRAPHIC 28934
  Complete submission text file 0001601485-26-000048.txt   1972927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20260617.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20260617_lab.xml EX-101.LAB 22516
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20260617_pre.xml EX-101.PRE 13037
22 EXTRACTED XBRL INSTANCE DOCUMENT angn-20260617_htm.xml XML 3010
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 261096636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)